RSV-F Vaccine

BIOLOGICAL3 trials

Sponsors

Novavax

Conditions

Respiratory Syncytial Virus (RSV)

Phase 2

Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults

CompletedNCT02266628

NovavaxRespiratory Syncytial Virus (RSV)

Start: 2014-10-31End: 2016-03-31Updated: 2022-05-27

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

CompletedNCT02593071

NovavaxRespiratory Syncytial Virus (RSV)

Start: 2015-10-31End: 2016-11-30Updated: 2022-05-27

Phase 3

A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults

CompletedNCT02608502

NovavaxRespiratory Syncytial Virus (RSV)

Start: 2015-11-30End: 2016-12-31Updated: 2022-07-19